Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinhua Miyanling
- Development stage
- Phase 4
- Lead developer
- Jilin Huakang Pharmaceutical
- Administration
- Oral
01
Overview
Yinhua Miyanling is a Traditional Chinese Medicine (TCM) formulation developed by Jilin Huakang Pharmaceutical. It is primarily available as a tablet and is composed of extracts from ten medicinal herbs, including *Lonicera japonica* (honeysuckle), *Lobelia chinensis*, and *Polygonum aviculare*. The drug is indicated for the treatment of urinary tract infections such as cystitis, urethritis, and pyelonephritis, particularly those associated with the TCM syndrome of 'damp-heat downward infusion.' It has also been investigated in Phase 3 clinical trials for the treatment of type III prostatitis (chronic prostatitis/chronic pelvic pain syndrome). The therapeutic action of Yinhua Miyanling is attributed to its combined antibacterial, anti-inflammatory, and diuretic properties.
- Brand names
- Yinhua Miyanling
- Other names
- Yinhua Miyanling TabletYinhua Miyanling Pian银花泌炎灵片
02
Targets
CASP1 (Caspase-1)MYD88 (Myeloid differentiation primary response protein MyD88)RELA (Nuclear Factor Kappa B Subunit p65)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)TLR4 (Toll-like receptor 4)RK (Ribokinase)AQP (Aquaporin family)
Beyond the preview
Go deeper on Yinhua Miyanling.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yinhua Miyanling.